Psychedelics
February 3, 2026
Sheida Shadani, Erika Greaves, Zane B. Andrews et al.
Psychedelics, particularly psilocybin, have shown therapeutic potential across several psychiatric conditions, including depression, anxiety, obsessive-compulsive disorder, and anorexia nervosa (AN). These disorders often share social deficits that may be effectively alleviated by psychedelics considering their use has been linked with emotional empathy and enhanced social cognition. However,...
Journal of Medical Internet Research
February 2, 2026
Julia Adams, Jonathan N. Davies, Prai Wattanatakulchat et al.
Meditation apps are increasingly popular, yet there is limited understanding of how much users actually engage with them. While meditation apps show promise for supporting mental health, engagement in real-world settings appears to be notably low. The patterns of app use and the factors that influence usage remain relatively unclear. This study aims to examine the extent of meditation app use...
Journal of Medical Internet Research
February 2, 2026
Riko Uwagawa, Koichiro Adachi, Mariko Shimoda et al.
Although working women experience increased work-related stress, preventive interventions to reduce its negative effects on their mental health are insufficient. This study evaluated the effectiveness of an 8-week mindfulness-based self-help intervention via a smartphone app across 4 domains (general psychological, work-related, family-related, and work-to-conflict) among working women. This...
Clinical Psychology Review
February 2, 2026
Jolien K E Veraart, Nina Schimmers, Joost J. Breeksema et al.
4 citations
Ketamine-assisted psychotherapy (KAP) is considered a promising treatment strategy in psychiatric disorders, combining psychotherapeutic interventions with the rapid-acting pharmacological effects of ketamine towards enhancing outcomes. Although KAP has been practiced for many years across different diagnoses, evidence regarding optimal treatment methods and working mechanisms remains limited...
Pharmacology, Biochemistry, and Behavior
February 2026
Alena Lemeshova, Kaya A Patel, Alexander J Bloom et al.
Ketamine, a nonselective NMDA-receptor antagonist, is an emerging therapeutic for treatment-resistant depression and could also be a promising treatment for anxiety and post-traumatic stress disorders. However, preclinical studies in these areas lack methodological standardization, limiting clinical translatability. This review evaluates ketamine's anxiolytic potential in rodents by examining...
Schizophrenia Bulletin
February 1, 2026
Huiying Nie, Liwei Zheng
Abstract Background In recent years, mental health problems among middle school students have shown a trend of younger age and diversification. Difficulty in emotional regulation has become a core factor affecting their academic performance and social adaptation. The research takes the improvement of middle school students’ emotional management ability as the core goal, proposes an intervention...
Indian Journal of Community Medicine
February 1, 2026
K H Naveen, Purnandu Sharma, Hemant Bhargav et al.
Meditation is a mind-body practice with many methods and variations. Initially practiced for self-realization, meditation has recently been recognized for its health benefits, with modern research exploring its medical applications. Mindfulness and transcendental meditation are the two major meditation types that are widely researched. Globally, the common noncommunicable diseases (NCDs),...
The Journal of Sexual Medicine
February 1, 2026
Hendrikus Knegtering, Thalia Herder, Nynke Boonstra et al.
Psychedelic-assisted therapy (PAT) is increasingly investigated as a treatment for depression, post-traumatic stress disorder (PTSD), and substance use disorder. In the United States (US) and European Union, esketamine has been approved for the treatment of depression, while psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) have received Breakthrough Therapy Designation in the US for...
Social Psychiatry and Psychiatric Epidemiology
February 1, 2026
Błażej Misiak, Julian Maciaszek
1 citation
Religiosity manifests in a variety of behaviors and activities that can be divided into intrinsic (IR), extrinsic organizational (EORG), and extrinsic non-organizational religiosity (ENORG). It has been shown that religiosity might be associated with the occurrence of psychotic-like experiences (PLEs). However, the understanding of this association might be limited due to a lack of longitudinal...
Current Opinion in Psychology
February 1, 2026
Karin Matko, Nicholas T. van Dam
4 citations
Despite the growing popularity of mindfulness, mindfulness-based programs (MBPs), and meditation, potential harms have largely been overlooked. Recent studies reveal that 25-87 % of those who engage in meditation report adverse effects (AEs), with 3-37 % experiencing functional impairment (e.g., inability to work). It remains unclear to what extent AEs reflect transitory discomfort vs. lasting...